Market Overview
The Global Medical Elastomers Market is expected to reach a valuation of
USD 4,521.5 million in 2023, and it is projected to experience a
CAGR of 13.8% for the forecast period (2023-2032). Elastomeric materials refer to substances displaying rubbery characteristics. An elastomer constitutes a polymer wherein the molecular connections rely on weak intermolecular forces. These materials find necessity in high-precision applications, like dental crowns or implants, where accuracy is paramount.
The market's growth is driven by the increasing acceptance of medical elastomers in the production of single-use medical devices such as syringes, valves, & tubing on a global scale. Additionally, the growing need for several implants, like artificial heart valves, is further fueling the demand for medical elastomers. These elastomers possess desirable properties, such as biocompatibility, durability, & resistance to chemicals & high temperatures and, making them ideal for the production of various
medical equipment like syringes, tubes, catheters, bags, & gloves. The United States comes out to be medical elastomers’ one of the largest consumers with significant growth anticipated over the forecast period. One of the major factors of the growth includes enhanced access to medical facilities & services for the people, aided by several initiatives of government for example, the ACA (Affordable Care Act) & Medicaid, etc.
Market Dynamic
Silicone, in particular, is anticipated to observe significant demand globally for the forecast period. Thanks to its extensive usage in producing medical elastomers. One such example can be applications in the encapsulation of medical items. Continuous advancements & developments in silicone-based advanced substances production are also expected to drive the growth of the market. The American Cancer Society stated that breast cancer stands as the predominant cancer impacting women in the United States, excluding skin cancer. It is frequently detected in women, particularly those in their middle and later stages of life.
The hormonal treatment for symptoms of menopause results in increased levels of estrogen, which is affecting women with cancer formation in the breast. Breast cancer treatment has led to a rise in the demand for silicone breast implants which is further fueling growth in the United States medical elastomer market in the coming years. The market in the United States is driven by major key players like Dow Inc., Eastman Chemical Co., & DuPont. Dominant players’ expertise & their presence in the field contribute to the further development of the market in the nation.
Moreover, the enhanced occurrence of the variants of COVID-19 variants has led to an increased number of patients, leading to a rise in demand for several healthcare parts such as syringes, gloves, catheters, masks, etc. thus boosting its demand for medical elastomers.
Research Scope and Analysis
By Type
The segment of thermoplastic elastomer dominates the medical elastomer market, accounting for a maximum share of the market in 2023. The type segment includes both thermoset elastomers & thermoplastic elastomers. This dominance of thermoplastic elastomers can be accredited to the rising spending on
healthcare facilities & on medical devices, such as plastic syringes, surgical gloves, instruments, & other items of plastic required in industrial applications. The growing desire for plastics that are less weighted, for example, thermoplastic elastomer, has been driven by these factors, especially in the medical sector. Additionally, the investment in R&D for coronavirus studies & vaccine development has led to a rise in the need for pharmaceutical lab & lab equipment.
However, it is crucial to consider that most plastic polymers are derived from crude oil, making their costs susceptible to fluctuations in global crude oil prices. Seasonal variations, supply & demand dynamics, natural disasters, & several other factors can lead to changes in the prices of crude oil, which can affect the overall thermoplastic elastomers’ cost.
By Application
The segment of medical tubes dominates the market, capturing the maximum share of the total revenue. The rising demand for such tubes in increasing patients suffering from a number of diseases such as lung cancer, pulmonary fibrosis, & asthma, is further propelling the elastomers’ requirements in the medical & healthcare sector. The ongoing innovations in the systems of drug delivery by the producers of healthcare equipment are driving the need for medical tubes that are customized. Moreover, the rising number of mergers & acquisitions among key players in the pharmaceutical device sector is anticipated to increase the demand for global single-use healthcare or medical equipment or devices, significantly fostering the growth of the market.
Another factor working behind the expansion of market size is the old age population and the rising prevalence of chronic diseases among them. Furthermore, the growing demand for less intrusive medical processes & single-use tube-based pharmaceutical devices is also driving the market’s growth.
The Medical Elastomers Market Report is segmented on the basis of the following
By Type
- Thermoset Elastomer
- Thermoplastic Elastomer
By Application
- Medical Bags
- Syringes
- Catheters
- Medical Tubes
- Implants
- Gloves
- Others
Regional Analysis
North America dominates the market for medical elastomers among other regions, capturing over maximum share of the total revenue. A major factor affecting this regional market’s growth is the rising investment in medical equipment in the United States especially in health insurance form. This growth in spending is significantly propelling the growth in the market in North America. Several uses of medical elastomers in this region encompass medical bags, medical tubing, syringes & implants.
Furthermore, Asia Pacific is anticipated to observe growth in the upcoming years. The medical sector in several nations like Australia, India & China is witnessing a higher desire for high-quality healthcare components & devices, driven by enhanced spending & investment in the medical sector. Moreover, the ongoing efforts to improve safety norms in medical centers are expected to further propel the demand for medical elastomers in Asia Pacific by 2032.
By Region
North America
• The U.S.
• Canada
Europe
• Germany
• The U.K.
• France
• Italy
• Russia
• Spain
• Benelux
• Nordic
• Rest of Europe
Asia-Pacific
• China
• Japan
• South Korea
• India
• ANZ
• ASEAN
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America
Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Israel
• Egypt
• Rest of MEA
Competitive Landscape
The manufacturers are actively involved in expanding their portfolio of medical elastomers and exploring their applications. In addition to innovation, they are focusing on streamlining the pre- and post-production processes to keep up with the rapid advancements in technology.
A notable development in the market occurred in November 2022 when Celanese successfully acquired the Mobility and Materials division of DuPont's thermoplastics and elastomers business. This strategic acquisition is expected to enhance Celanese's product offerings and strengthen its production capabilities for elastomers and thermoplastics. As a result, the availability of medical elastomers is set to increase, further contributing to the market's growth and meeting the rising demand for innovative medical elastomer-based products.
Some of the prominent players in the Medical Elastomers Market are:
- DOW
- Celanese Corporation
- Solvay
- BASF SE
- DuPont
- DSM
- Kuraray Co., Ltd.
- Teknor Apex
- Momentive
- Trelleborg AB
- Biomerics, LLC
- HEXPOL AB
- Other Key Players
COVID-19 Pandemic & Recession: Impact on the Medical Elastomers Market
The Covid-19 pandemic and the ensuing global recession have had a significant impact on the medical elastomers market. The outbreak led to unprecedented disruptions in healthcare systems, manufacturing, and supply chains, affecting the medical industry as a whole. During the pandemic, there was an urgent surge in demand for medical equipment and devices, including gloves, masks, syringes, and other essential medical components, which boosted the demand for medical elastomers. However, the pandemic also resulted in challenges like reduced production capacity, logistical constraints, and material shortages, which hampered the supply chain and led to temporary fluctuations in market dynamics. Additionally, the economic downturn and financial uncertainties led to deferred investments and cautious spending in the healthcare sector, affecting the overall demand for medical elastomers. As the world gradually recovers from the pandemic and economies stabilize, the medical elastomers market is expected to regain momentum, driven by resuming healthcare activities, increased focus on medical research and development, and the rising need for advanced medical devices and equipment.
Report Details
| Report Characteristics |
| Market Size (2023) |
USD USD 4,521.5 Mn |
| Forecast Value (2032) |
USD 14,473.4 Mn |
| CAGR (2023-2032) |
13.8% |
| Historical Data |
2017 - 2022 |
| Forecast Data |
2023 - 2032 |
| Base Year |
2022 |
| Estimate Year |
2023 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Type (Thermoset Elastomer, and Thermoplastic
Elastomer), By Application (Medical Bags, Syringes,
Catheters, Medical Tubes, Implants, Gloves, and
Others). |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
DOW, Celanese Corporation, Solvay, BASF SE,
DuPont, DSM, Kuraray Co., Ltd., Teknor Apex,
Momentive, Trelleborg AB, Biomerics, LLC, HEXPOL
AB, and Other Key Players. |
| Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |
Frequently Asked Questions
The Global Medical Elastomers Market is expected to reach a valuation of USD 4,521.5 million in 2023.
The Medical Elastomers Market is expected to grow at 13.8% (CAGR) from 2023 to 2032.
North America dominates the market for medical elastomers, capturing over 40.4% share of the global
revenue.
Some of the prominent players in the Medical Elastomers Market include DOW, Celanese Corporation,
Solvay, BASF SE, DuPont, DSM, etc.